Gushengtang Expands Share Buyback and Seeks Fresh Repurchase Mandate

Gushengtang Holdings Limited ( (HK:2273) ) just unveiled an announcement.

Gushengtang Holdings Limited has announced a further use of its existing share repurchase mandate, approving an additional on-market buyback of up to HK$300 million in shares, funded from internal resources and excluding proceeds from prior equity offerings. The repurchased shares will be either cancelled or held in treasury, with the board stating that the move is intended to enhance share value, signal confidence in the company’s long-term prospects, and still preserve sufficient resources for ongoing business growth.

Given the expanded repurchase activity and current usage of the existing mandate, the board plans to seek shareholder approval at an extraordinary general meeting to refresh and vary the repurchase mandate, revoking the unutilized portion of the current authorization once the new mandate is approved. This step is designed to provide ongoing flexibility for further share repurchases in compliance with Hong Kong listing rules and applicable laws, underlining the company’s continued focus on capital management and shareholder returns.

The most recent analyst rating on (HK:2273) stock is a Sell with a HK$24.50 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.

More about Gushengtang Holdings Limited

Gushengtang Holdings Limited is a Hong Kong-listed company engaged in the healthcare sector, operating through a group structure with subsidiaries and consolidated affiliated entities. The company focuses on providing medical and health-related services, positioning itself in a market where capital allocation and shareholder returns are key elements of its strategy.

Average Trading Volume: 1,429,762

Technical Sentiment Signal: Sell

Current Market Cap: HK$6.56B

See more data about 2273 stock on TipRanks’ Stock Analysis page.